NF-κB and IRF1 induce endogenous retrovirus K expression via interferon-stimulated response elements in Its 5' long terminal repeat

Journal of Virology

Volumn 90, Issue 20, 2016, Pages 9338-9349

  Manghera, Mamneet ^a   Ferguson Parry, Jennifer ^a   Lin, Rongtuan ^b   Douville, Renée N ^a,c  

^a UNIVERSITY OF WINNIPEG   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; GAMMA INTERFERON; INTERFERON; IRF1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOGENOUS RETROVIRUS; ENDOGENOUS RETROVIRUS K; FEMALE; GENE EXPRESSION; GENE STRUCTURE; HUMAN; HUMAN TISSUE; INTERFERON STIMULATED RESPONSE ELEMENT; LONG TERMINAL REPEAT; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; VERY ELDERLY; VIRUS REACTIVATION; VIRUS TRANSCRIPTION; CELL CULTURE; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HEK293 CELL LINE; INFLAMMATION; METABOLISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VIROLOGY;

AGED; AGED, 80 AND OVER; CELLS, CULTURED; ENDOGENOUS RETROVIRUSES; FEMALE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; INFLAMMATION; INTERFERON REGULATORY FACTOR-1; INTERFERON-GAMMA; INTERFERONS; MALE; MIDDLE AGED; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84990041401     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01503-16     Document Type: Article

References (55)

1. Manghera M, Douville RN. 2013. Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors? Retrovirology 10:16. http://dx.doi.org/10.1186/1742-4690-10-16.
2. Battistini A, Marsili G, Sgarbanti M, Ensoli B, Hiscott J. 2002. IRF regulation of HIV-1 long terminal repeat activity. J Interferon Cytokine Res 22:27-37. http://dx.doi.org/10.1089/107999002753452638.
3. Sgarbanti M, Borsetti A, Moscufo N, Bellocchi MC, Ridolfi B, Nappi F, Marsili G, Marziali G, Coccia EM, Ensoli B, Battistini A. 2002. Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. J Exp Med 195:1359-1370. http://dx.doi.org/10.1084/jem.20010753.
4. Klatt NR, Chomont N, Douek DC, Deeks SG. 2013. Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunol Rev 254:326-342. http://dx.doi.org/10.1111/imr.12065.
5. Freimanis G, Hooley P, Ejtehadi HD, Ali HA, Veitch A, Rylance PB, Alawi A, Axford J, Nevill A, Murray PG, Nelson PN. 2010. A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis. Clin Exp Immunol 160:340-347. http://dx.doi.org/10.1111/j.1365-2249.2010.04110.x.
6. Serra C, Mameli G, Arru G, Sotgiu S, Rosati G, Dolei A. 2003. In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis. J Neurovirol 9:637-643.
7. Mameli G, Astone V, Arru G, Marconi S, Lovato L, Serra C, Sotgiu S, Bonetti B, Dolei A. 2007. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/ HERV-W endogenous retrovirus, but not human herpesvirus 6. J Gen Virol 88:264-274. http://dx.doi.org/10.1099/vir.0.81890-0.
8. Renton AE, Chio A, Traynor BJ. 2014. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17:17-23. http://dx.doi.org/10.1038/nn.3584.
9. McCormick AL, Brown RH, Jr, Cudkowicz ME, Al-Chalabi A, Garson JA. 2008. Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology 70:278-283. http://dx.doi.org/10.1212/01.wnl.0000297552.13219.b4.
10. MacGowan DJ, Scelsa SN, Imperato TE, Liu KN, Baron P, Polsky B. 2007 A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS. Neurology 68:1944-1946. http://dx.doi.org/10.1212/01.wnl.0000263188.77797.99.
11. Douville R, Liu J, Rothstein J, Nath A. 2011. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann Neurol 69:141-151. http://dx.doi.org/10.1002/ana.22149.
12. Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, Campanac E, Hoffman DA, von Geldern G, Johnson K, Maric D, Morris HD, Lentz M, Pak K, Mammen A, Ostrow L, Rothstein J, Nath A. 2015. Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med 7:307ra153. http://dx.doi.org/10.1126/scitranslmed.aac8201.
13. Poloni M, Facchetti D, Mai R, Micheli A, Agnoletti L, Francolini G, Mora G, Camana C, Mazzini L, Bachetti T. 2000. Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett 287: 211-214. http://dx.doi.org/10.1016/S0304-3940(00)01177-0.
14. Tateishi T, Yamasaki R, Tanaka M, Matsushita T, Kikuchi H, Isobe N, Ohyagi Y, Kira J. 2010. CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis. J Neuroimmunol 222:76-81. http://dx.doi.org/10.1016/j.jneuroim.2010.03.004.
15. Babu GN, Kumar A, Chandra R, Puri SK, Kalita J, Misra UK. 2008. Elevated inflammatory markers in a group of amyotrophic lateral sclerosis patients from northern India. Neurochem Res 33:1145-1149. http://dx.doi.org/10.1007/s11064-007-9564-x.
16. Olmos G, Llado J. 2014. Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediators Inflamm 2014:861231. http://dx.doi.org/10.1155/2014/861231.
17. McCoy MK, Tansey MG. 2008. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 5:45. http://dx.doi.org/10.1186/1742-2094-5-45.
18. Aebischer J, Moumen A, Sazdovitch V, Seilhean D, Meininger V, Raoul C. 2012. Elevated levels of IFNgamma and LIGHT in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. Eur J Neurol 19:752-759, e45-e56. http://dx.doi.org/10.1111/j.1468-1331.2011.03623.x.
19. Aebischer J, Cassina P, Otsmane B, Moumen A, Seilhean D, Meininger V, Barbeito L, Pettmann B, Raoul C. 2011. IFNgamma triggers a LIGHTdependent selective death of motoneurons contributing to the non-cellautonomous effects of mutant SOD1. Cell Death Differ 18:754-768. http://dx.doi.org/10.1038/cdd.2010.143.
20. Otsmane B, Moumen A, Aebischer J, Coque E, Sar C, Sunyach C, Salsac C, Valmier J, Salinas S, Bowerman M, Raoul C. 2014. Somatic and axonal LIGHT signaling elicit degenerative and regenerative responses in motoneurons, respectively. EMBO Rep 15:540-547. http://dx.doi.org/10.1002/embr.201337948.
21. Ware CF. 2005. Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 23:787-819. http://dx.doi.org/10.1146/annurev.immunol.23.021704.115719.
22. Neish AS, Read MA, Thanos D, Pine R, Maniatis T, Collins T. 1995. Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 15:2558-2569. http://dx.doi.org/10.1128/MCB.15.5.2558.
23. Mir M, Asensio VJ, Tolosa L, Gou-Fabregas M, Soler RM, Llado J, Olmos G. 2009. Tumor necrosis factor alpha and interferon gamma cooperatively induce oxidative stress and motoneuron death in rat spinal cord embryonic explants. Neuroscience 162:959-971. http://dx.doi.org/10.1016/j.neuroscience.2009.05.049.
24. Paludan SR. 2000. Synergistic action of pro-inflammatory agents: cellular and molecular aspects. J Leukoc Biol 67:18-25.
25. Akizuki M, Yamashita H, Uemura K, Maruyama H, Kawakami H, Ito H, Takahashi R. 2013. Optineurin suppression causes neuronal cell death via NF-kappaB pathway. J Neurochem 126:699-704. http://dx.doi.org/10.1111/jnc.12326.
26. Major EO, Miller AE, Mourrain P, Traub RG, de Widt E, Sever J. 1985. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc Natl Acad Sci U S A 82:1257-1261. http://dx.doi.org/10.1073/pnas.82.4.1257.
27. Donato R, Miljan EA, Hines SJ, Aouabdi S, Pollock K, Patel S, Edwards FA, Sinden JD. 2007. Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci 8:36. http://dx.doi.org/10.1186/1471-2202-8-36.
28. Sharma S, ten Oever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151. http://dx.doi.org/10.1126/science.1081315.
29. Manghera M, Ferguson J, Douville R. 2015. ERVK polyprotein processing and reverse transcriptase expression in human cell line models of neurological disease. Viruses 7:320-332. http://dx.doi.org/10.3390/v7010320.
30. Tolosa L, Caraballo-Miralles V, Olmos G, Llado J. 2011. TNF-alpha potentiates glutamate-induced spinal cord motoneuron death via NFkappaB. Mol Cell Neurosci 46:176-186. http://dx.doi.org/10.1016/j.mcn.2010.09.001.
31. Rettino A, Clarke NM. 2013. Genome-wide identification of IRF1 bind-ing sites reveals extensive occupancy at cell death associated genes. J Carcinog Mutagen 2013(Spec Iss Apoptosis):S6-009. http://dx.doi.org/10.4172/2157-2518.S6-009.
32. Sgarbanti M, Remoli AL, Marsili G, Ridolfi B, Borsetti A, Perrotti E, Orsatti R, Ilari R, Sernicola L, Stellacci E, Ensoli B, Battistini A. 2008. IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer. J Virol 82:3632-3641. http://dx.doi.org/10.1128/JVI.00599-07.
33. Fuchs NV, Kraft M, Tondera C, Hanschmann KM, Lower J, Lower R. 2011 Expression of the human endogenous retrovirus (HERV) group HML-2/HERV-K does not depend on canonical promoter elements but is regulated by transcription factors Sp1 and Sp3. J Virol 85:3436-3448. http://dx.doi.org/10.1128/JVI.02539-10.
34. Saura M, Zaragoza C, Bao C, McMillan A, Lowenstein CJ. 1999. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription. J Mol Biol 289:459-471. http://dx.doi.org/10.1006/jmbi.1999.2752.
35. Azimi N, Shiramizu KM, Tagaya Y, Mariner J, Waldmann TA. 2000. Viral activation of interleukin-15 (IL-15): characterization of a virusinducible element in the IL-15 promoter region. J Virol 74:7338-7348. http://dx.doi.org/10.1128/JVI.74.16.7338-7348.2000.
36. Drew PD, Franzoso G, Becker KG, Bours V, Carlson LM, Siebenlist U, Ozato K. 1995. NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. J Interferon Cytokine Res 15:1037-1045.
37. Merika M, Williams AJ, Chen G, Collins T, Thanos D. 1998. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol Cell 1:277-287. http://dx.doi.org/10.1016/S1097-2765(00)80028-3.
38. Akassoglou K, Probert L, Kontogeorgos G, Kollias G. 1997. Astrocytespecific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 158:438-445.
39. Bista P, Zeng W, Ryan S, Bailly V, Browning JL, Lukashev ME. 2010. TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor. J Biol Chem 285:12971-12978. http://dx.doi.org/10.1074/jbc.M109.076091.
40. Hayden MS, Ghosh S. 2012. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 26:203-234. http://dx.doi.org/10.1101/gad.183434.111.
41. Zhou Z, Peng X, Insolera R, Fink DJ, Mata M. 2009. Interleukin-10 provides direct trophic support to neurons. J Neurochem 110:1617-1627. http://dx.doi.org/10.1111/j.1471-4159.2009.06263.x.
42. Kunsch C, Ruben SM, Rosen CA. 1992. Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol Cell Biol 12:4412-4421 http://dx.doi.org/10.1128/MCB.12.10.4412.
43. Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E, Greene WC. 2006. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J 25:139-149 http://dx.doi.org/10.1038/sj.emboj.7600900.
44. Kaltschmidt B, Kaltschmidt C. 2009. NF-kappaB in the nervous system. Cold Spring Harb Perspect Biol 1:a001271. http://dx.doi.org/10.1101/cshperspect.a001271.
45. Nair S, Michaelsen-Preusse K, Finsterbusch K, Stegemann-Koniszewski S, Bruder D, Grashoff M, Korte M, Koster M, Kalinke U, Hauser H, Kroger A. 2014. Interferon regulatory factor-1 protects from fatal neurotropic infection with vesicular stomatitis virus by specific inhibition of viral replication in neurons. PLoS Pathog 10:e1003999. http://dx.doi.org/10.1371/journal.ppat.1003999.
46. Boyault C, Zhang Y, Fritah S, Caron C, Gilquin B, Kwon SH, Garrido C, Yao TP, Vourc'h C, Matthias P, Khochbin S. 2007. HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev 21:2172-2181. http://dx.doi.org/10.1101/gad.436407.
47. Olzmann JA, Li L, Chin LS. 2008. Aggresome formation and neurodegenerative diseases: therapeutic implications. Curr Med Chem 15:47-60. http://dx.doi.org/10.2174/092986708783330692.
48. Janssens J, Van Broeckhoven C. 2013. Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders. Hum Mol Genet 22:R77-R87. http://dx.doi.org/10.1093/hmg/ddt349.
49. Manghera M, Ferguson-Parry J, Douville RN. 2016. TDP-43 regulates endogenous retrovirus-K viral protein accumulation. Neurobiol Dis 94: 226-236. http://dx.doi.org/10.1016/j.nbd.2016.06.017.
50. Lucas SM, Rothwell NJ, Gibson RM. 2006. The role of inflammation in CNS injury and disease. Br J Pharmacol 147(Suppl 1):S232-S240.
51. Dahm T, Rudolph H, Schwerk C, Schroten H, Tenenbaum T. 2016. Neuroinvasion and inflammation in viral central nervous system infections. Mediators Inflamm 2016:8562805. http://dx.doi.org/10.1155/2016/8562805.
52. Majde JA. 2010. Neuroinflammation resulting from covert brain invasion by common viruses-a potential role in local and global neurodegeneration. Med Hypotheses 75:204-213. http://dx.doi.org/10.1016/j.mehy.2010.02.023.
53. Scarisbrick IA, Rodriguez M. 2003. Hit-hit and hit-run: viruses in the playing field of multiple sclerosis. Curr Neurol Neurosci Rep 3:265-271. http://dx.doi.org/10.1007/s11910-003-0087-9.
54. Christensen T. 2010. HERVs in neuropathogenesis. J Neuroimmune Pharmacol 5:326-335. http://dx.doi.org/10.1007/s11481-010-9214-y.
55. Robberecht W, Jubelt B. 2005. Reverse transcriptase takes ALS back to viruses. Neurology 64:410-411. http://dx.doi.org/10.1212/01.WNL.0000150927.53939.98.